Moving AAV gene therapy beyond rare disease to address large patient populations with chronic disease

Dan Oliver, Ji Hyun Lee

09 April 2025

Register

Investing in early-stage stem cell therapy developers

Stijn Heessen, Kristian Tryggvason

21 February 2025

Viewpoint

The Nordics are dancing on

Helena Strigard

23 January 2025

Conference Insight

When does outsourcing autologous collection center qualification and the cell therapy supply chain make sense?

Amy Hines, Jeni Newman, Marcel van Houten

14 November 2024

Watch

Shifting to non-viral in vivo therapies to enhance global patient access to genetic medicines

Hari Pujar

27 September 2024

Interview

Navigating the European landscape of advanced therapy funding and commercialization

Dmitry A Kuzmin

03 September 2024

Interview

Driving digital innovation for supply chain orchestration in cell and gene therapy

Christian Fuchs

28 August 2024

Interview

What are the issues associated with developing gene therapies for rare disease and are the current development models working?

Samir Nuseibeh, Els Henckaerts

20 June 2024

Commentary

Best practices and considerations for outsourcing with CDMOs

Joseph W Graskemper

11 April 2024

Viewpoint

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust

05 April 2024

Viewpoint

Insights into advanced therapies in the context of evolving funding and M&A environments

Lee Brown

26 March 2024

Interview

Human capital comes with a memory

Helena Strigard

25 March 2024

Viewpoint

2024: the year of the genome editing technologies?

Harriet Edwards

25 March 2024

Viewpoint

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

L Munsie, K Raineri, M Carpenter et al

05 March 2024

Watch

Wall Street analyst’s perspective: taking the pulse of the nucleic acid-based prophylactic & therapeutic vaccine sectors

Hartaj Singh

23 February 2024

Interview

Empowering the tissue engineered product field

Michael Lehmicke, Natalie Fekete

16 February 2024

Interview

Empowering the future of cell therapy: leveraging partnerships to support advancement

J Patarroyo, F Mack, X de Mollerat du Jeu et al

23 November 2023

Innovator Insight

A new era in medicine: unraveling the evolution and future of gene therapy

M Tanaka-Wakefield, J Ark, Y Gambhir et al

25 October 2023

Commentary

Empowering the future of cell therapy: leveraging partnerships to support advancement

J Patarroyo, F Mack, X de Mollerat du Jeu et al

21 September 2023

Watch

European research infrastructures join forces to provide innovative cancer research services across Europe—how can they support the cell and gene therapy developer?

E Oldoni, P Carvajal-Vallejos, F Bietrix et al

11 August 2023

Editorial

Early-stage considerations for accelerating cell and gene therapy commercialization

Sabrina Carmichael

11 July 2023

Watch